Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
15,083 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00264446 | A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection | completed | Phase 1 | — | Adherex Technologies, Inc.INDUSTRY | 1 | Aug 6, 2007 | clinicaltrials |
| NCT00100347 | Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors | terminated | Phase 1 | 45 | PRAECIS Pharmaceuticals Inc.INDUSTRY | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00186108 | A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer | completed | Phase 1 | 23 | Stanford UniversityOTHER | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00107094 | Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer | completed | Phase 1 | 30 | Celgene CorporationINDUSTRY | 1 | Jul 20, 2007 | clinicaltrials |
| NCT00195078 | Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer | terminated | Phase 1 / Phase 2 | 29 | Weill Medical College of Cornell UniversityOTHER | 1 | Jul 20, 2007 | clinicaltrials |
| NCT00070837 | MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer | completed | Phase 1 / Phase 2 | 46 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 13, 2007 | clinicaltrials |
| NCT00105313 | Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia | terminated | Phase 1 | 80 | MedImmune LLCINDUSTRY | 1 | Jun 14, 2007 | clinicaltrials |
| NCT00394628 | AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme | unknown | Phase 1 / Phase 2 | 60 | NovaceaINDUSTRY | 1 | May 30, 2007 | clinicaltrials |
| NCT00080041 | Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors | completed | Phase 1 | 20 | Pharmacyclics LLC.INDUSTRY | 1 | May 15, 2007 | clinicaltrials |
| NCT00126893 | Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia | terminated | Phase 1 | 36 | Celgene CorporationINDUSTRY | 1 | May 15, 2007 | clinicaltrials |
| NCT00255333 | INNO-105 in Patients With Solid Tumors | terminated | Phase 1 | 24 | Innovive PharmaceuticalsINDUSTRY | 1 | May 14, 2007 | clinicaltrials |
| NCT00091585 | Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors. | completed | Phase 1 | — | Sunesis PharmaceuticalsINDUSTRY | 1 | May 10, 2007 | clinicaltrials |
| NCT00094159 | Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors | completed | Phase 1 | — | Sunesis PharmaceuticalsINDUSTRY | 1 | May 10, 2007 | clinicaltrials |
| NCT00080028 | Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer | terminated | Phase 1 | 18 | Pharmacyclics LLC.INDUSTRY | 1 | May 8, 2007 | clinicaltrials |
| NCT00066885 | Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 80 | NovaceaINDUSTRY | 1 | May 7, 2007 | clinicaltrials |
| NCT00109356 | Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia | unknown | Phase 1 / Phase 2 | 55 | NovaceaINDUSTRY | 1 | May 7, 2007 | clinicaltrials |
| NCT00299780 | Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. | completed | Phase 1 | 12 | Massachusetts General HospitalOTHER | 1 | Apr 24, 2007 | clinicaltrials |
| NCT00462189 | Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease | unknown | Phase 1 | 40 | Cambridge Antibody TechnologyOTHER | 3 | Apr 18, 2007 | clinicaltrials |
| NCT00457860 | Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease | unknown | Phase 1 | 50 | Cambridge Antibody TechnologyOTHER | 2 | Apr 17, 2007 | clinicaltrials |
| NCT00089596 | Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers | completed | Phase 1 / Phase 2 | 10 | ViaCellINDUSTRY | 1 | Apr 12, 2007 | clinicaltrials |
| NCT00033878 | Study of Noni in Cancer Patients | completed | Phase 1 | — | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Mar 28, 2007 | clinicaltrials |
| NCT00076609 | Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 31 | PhytoCeuticaINDUSTRY | 2 | Mar 28, 2007 | clinicaltrials |
| NCT00195247 | Study Evaluating TTI-237 in Advanced Malignant Solid Tumors | terminated | Phase 1 | 45 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Mar 26, 2007 | clinicaltrials |
| NCT00195325 | Study Evaluating TTI-237 in Advanced Malignant Solid Tumors. | terminated | Phase 1 | 45 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Mar 26, 2007 | clinicaltrials |
| NCT00052000 | A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer | completed | Phase 1 | 29 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 1, 2007 | clinicaltrials |
| NCT00071136 | Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00034034 | Acupuncture to Reduce Symptoms of Advanced Colorectal Cancer | completed | Phase 1 | 105 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jan 5, 2007 | clinicaltrials |
| NCT00074646 | Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas | completed | Phase 1 | 36 | Celgene CorporationINDUSTRY | 1 | Jan 4, 2007 | clinicaltrials |
| NCT00088647 | Study Evaluating MST-997 in Advanced Malignant Solid Tumors | terminated | Phase 1 | — | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 8, 2006 | clinicaltrials |
| NCT00277836 | Study Evaluating MST-997 in Advanced Malignant Solid Tumors | terminated | Phase 1 | 60 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 8, 2006 | clinicaltrials |
| NCT00062907 | Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer | unknown | Phase 1 | 9 | Corixa CorporationINDUSTRY | 1 | Dec 6, 2006 | clinicaltrials |
| NCT00214838 | An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer | unknown | Phase 1 / Phase 2 | 61 | Callisto PharmaceuticalsINDUSTRY | 1 | Dec 5, 2006 | clinicaltrials |
| NCT00058656 | Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients | completed | Phase 1 / Phase 2 | 18 | Xcyte TherapiesINDUSTRY | 1 | Nov 22, 2006 | clinicaltrials |
| NCT00074854 | A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy | completed | Phase 1 / Phase 2 | 87 | PfizerINDUSTRY | 1 | Nov 9, 2006 | clinicaltrials |
| NCT00132756 | Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer | terminated | Phase 1 / Phase 2 | 30 | Morton Plant Mease Health CareOTHER | 1 | Nov 8, 2006 | clinicaltrials |
| NCT00174356 | PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients | completed | Phase 1 | 39 | PfizerINDUSTRY | 2 | Nov 8, 2006 | clinicaltrials |
| NCT00048464 | T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant | unknown | Phase 1 / Phase 2 | 35 | Xcyte TherapiesINDUSTRY | 1 | Nov 7, 2006 | clinicaltrials |
| NCT00104286 | Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumors | terminated | Phase 1 / Phase 2 | 50 | SGX Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 3, 2006 | clinicaltrials |
| NCT00090727 | Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma | unknown | Phase 1 | 45 | NovaceaINDUSTRY | 1 | Nov 2, 2006 | clinicaltrials |
| NCT00195156 | Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies | terminated | Phase 1 | — | Weill Medical College of Cornell UniversityOTHER | 1 | Sep 14, 2006 | clinicaltrials |
| NCT00178243 | Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation | completed | Phase 1 / Phase 2 | — | University of RochesterOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00101842 | Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer | completed | Phase 1 / Phase 2 | 61 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 29, 2006 | clinicaltrials |
| NCT00082303 | Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin's Lymphoma | completed | Phase 1 / Phase 2 | 60 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00034463 | ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer | completed | Phase 1 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00034502 | A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer. | completed | Phase 1 / Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 2 | Jul 19, 2006 | clinicaltrials |
| NCT00001533 | Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine | completed | Phase 1 | 25 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jul 17, 2006 | clinicaltrials |
| NCT00001579 | A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors | completed | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Jul 17, 2006 | clinicaltrials |
| NCT00337064 | Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women | unknown | Phase 1 / Phase 2 | 75 | University of VermontOTHER | 1 | Jun 15, 2006 | clinicaltrials |
| NCT00318513 | Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema | unknown | Phase 1 | 35 | Premiere Oncology of ArizonaOTHER | 1 | May 10, 2006 | clinicaltrials |
| NCT00082472 | Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) | unknown | Phase 1 / Phase 2 | 30 | ZivenaINDUSTRY | 1 | Apr 18, 2006 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials